Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Added Value of CT Scanning for Discriminating Malignant From Non-malignant Causes in Patients With an Unilateral Pleural Effusion

NCT03270215 is registered in ClinicalTrials.gov with Naestved Hospital as lead sponsor.

NCT NCT03270215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03270215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Added Value of CT Scanning for Discriminating Malignant From Non-malignant Causes in Patients With an Unilateral Pleural Effusion
Lead sponsor
Naestved Hospital
Phase
Observational
Overall status
Completed
Start date
October 1, 2017
Completion date
January 30, 2019
Enrollment
232 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pleural effusion, malignant